Smith & Howard Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,540
Closed -$1.64M 91
2019
Q3
$1.64M Hold
16,540
0.65% 24
2019
Q2
$1.53M Hold
16,540
0.65% 19
2019
Q1
$1.56M Hold
16,540
0.77% 18
2018
Q4
$1.06M Hold
16,540
0.58% 19
2018
Q3
$1.48M Hold
16,540
0.62% 18
2018
Q2
$1.31M Sell
16,540
-75
-0.5% -$6.23K 0.58% 18
2018
Q1
$1.48M Buy
16,615
+75
+0.5% +$7.2K 0.64% 17
2017
Q4
$1.73M Hold
16,540
0.81% 14
2017
Q3
$2.41M Sell
16,540
-2,144
-11% -$292K 1.15% 12
2017
Q2
$2.43M Hold
18,684
1.16% 13
2017
Q1
$2.33M Buy
+18,684
New +$2.24M 1.12% 14
2015
Q3
Sell
-1,985
Closed -$230K 90
2015
Q2
$230K Sell
1,985
-186
-9% -$21.3K 0.1% 73
2015
Q1
$250K Buy
2,171
+240
+12% +$28.7K 0.11% 63
2014
Q4
$216K Buy
+1,931
New +$204K 0.1% 46

Other funds holding CELG

Smith & Howard Wealth Management's CELG Position: Q4 2019 in Review

Smith & Howard Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,540 shares — an estimated $1.64M sold.

Smith & Howard Wealth Management first reported a position in CELG in Q4 2014 and held it in 14 quarters. The position peaked at $2.43M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Smith & Howard Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Smith & Howard Wealth Management sold 16,540 Celgene Corp shares in Q4 2019, an estimated $1.64M.
  • Smith & Howard Wealth Management first reported a position in Celgene Corp in Q4 2014 and held it in 14 quarters.
  • Smith & Howard Wealth Management's Celgene Corp position peaked at $2.43M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Smith & Howard Wealth Management's 13F filing for Q4 2019, filed 13 Jan 2020.